Regulation of type IV collagen α chains of glomerular epithelial cells in diabetic conditions

Journal of Korean Medical Science

Volumn 24, Issue 5, 2009, Pages 837-843

  Ha, Tae Sun ^a   Hong, Eun Jeong ^a   Ahn, Eun Mi ^a   Ahn, Hee Yul ^a  

^a Chungbuk National University   (South Korea)

Author keywords

Advanced; Collagen type IV; Diabetic nephropathies; Glucose; Glycosylation end products; Podocytes

Indexed keywords

ADVANCED GLYCATION END PRODUCT; COLLAGEN TYPE 4; GLUCOSE; MESSENGER RNA;

ANIMAL; ARTICLE; CELL CULTURE; DIABETIC NEPHROPATHY; EPITHELIUM CELL; GENETICS; GLOMERULUS BASEMENT MEMBRANE; MALE; METABOLISM; PHYSIOLOGY; PODOCYTE; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CELLS, CULTURED; COLLAGEN TYPE IV; DIABETIC NEPHROPATHIES; EPITHELIAL CELLS; GLOMERULAR BASEMENT MEMBRANE; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; MALE; PODOCYTES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 75349094692     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2009.24.5.837     Document Type: Article

References (30)

1. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 2001; 37: 1053-9.
2. Sharma K, Ziyadeh FN. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 1995; 44: 1139-46.
3. Cooper ME. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 1998; 352: 213-9.
4. Ziyadeh FN, Sharma K, Ericksen M, Wolf G. Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest 1994; 93: 536-42.
5. Hoffman B, Sharma K, Zhu Y, Ziyadeh FN. Transcriptional activation of transforming growth factor-beta1 in mesangial cell culture by high glucose concentration. Kidney Int 1998; 54: 1107-16.
6. Ziyadeh FN. The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 1993; 22: 736-44.
7. Yurchenco PD, Smirnov S, Mathus T. Analysis of basement membrane self-assembly and cellular interactions with native and recombinant glycoproteins. Methods Cell Biol 2002; 69: 111-44.
8. Aumailley M, Gayraud B. Structure and biological activity of the extracellular matrix. J Mol Med 1998; 76: 253-65.
9. Miner JH. Renal basement membrane components. Kidney Int 1999; 56: 2016-24.
10. Hostikka, SL, Eddy RL, Byers MG, Hoyhtya M, Shows TB, Tryggvason K. Identification of a distinct type IV collagen alpha chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome. Proc Natl Acad Sci USA 1990; 87: 1606-10.
11. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 2003; 348: 2543-56.
12. Timpl R, Wiedemann H, van Delden V, Furthmayr H, Kuhn K. A network model for the organization of type IV collagen molecules in basement membranes. Eur J Biochem 1981; 120: 203-11.
13. Boutaud A, Borza DB, Bondar O, Gunwar S, Netzer KO, Singh N, Ninomiya Y, Sado Y, Noelken ME, Hudson BG. Type IV collagen of the glomerular basement membrane: evidence that the chain specificity of network assembly is encoded by the noncollagenous NC1 domains. J Biol Chem 2000; 275: 30716-24.
14. Kreisberg JI, Hoover RL, Karnovsky MJ. Isolation and characterization of rat glomerular epithelial cells in vitro. Kidney Int 1978; 14: 21-30.
15. Ha TS, Song CJ, Lee JH. Effects of advanced glycosylation endproducts on perlecan core protein of glomerular epithelium. Pediatr Nephrol 2004; 19: 1219-24.
16. Zhu D, Kim Y, Steffes MW, Groppoli TJ, Butkowski RJ, Mauer SM. Glomerular distribution of type IV collagen in diabetes by high resolution quantitative immunochemistry. Kidney Int 1994; 45: 425-33.
17. Wolf G, Chen S, Ziyadeh FN. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 2005; 54: 1626-34.
18. Isogai S, Mogami K, Shiina N, Yoshino G. Initial ultrastructural changes in pore size and anionic sites of the glomerular basement membrane in streptozotocin-induced diabetic rats and their prevention by insulin treatment. Nephron 1999; 83: 53-8.
19. Sharma K, Ziyadeh FN. Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. Semin Nephrol 1997; 17: 80-92.
20. White KE, Bilous RW, Diabiopsies Study Group. Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients. Nephrol Dial Transplant 2004; 19: 1437-40.
21. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UK-PDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-53.
22. Miner JH, Sanes JR. Collagen IV alpha 3, alpha 4, and alpha 5 chains in rodent basal laminae: sequence, distribution, association with laminins, and developmental switches. J Cell Biol 1994; 127: 879-91.
23. Miner JH. Developmental biology of glomerular basement membrane components. Curr Opin Nephrol Hypertens 1998; 7: 13-9.
24. Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H. ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 1992; 41: 1520-7.
25. Kang SW, Natarajan R, Shahed A, Nast CC, LaPage J, Mundel P, Kashtan C, Adler SG. Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen α5(IV) in experimental diabetic nephropathy and in glucose-stimulated podocytes. J Am Soc Nephrol 2003; 14: 3178-87.
26. Cohen MP, Lautenslager GT, Hud E, Shea E, Wang A, Chen S, Shearman CW. Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency. Am J Physiol Renal Physiol 2007; 292: F789-95.
27. Kim Y, Kleppel MM, Butkowski R, Mauer SM, Wieslander J, Michael AF. Differential expression of basement membrane collagen chains in diabetic nephropathy. Am J Pathol 1991; 138: 413-20.
28. Yagame M, Kim Y, Zhu D, Suzuki D, Eguchi K, Nomoto Y, Sakai H, Groppoli T, Steffes MW, Mauer SM. Differential distribution of type IV collagen chains in patients with diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 1995; 70: 42-8.
29. Bai Y, Wang L, Li Y, Liu S, Li J, Wang H, Huang H. High ambient glucose levels modulates the production of MMP-9 and α5(IV) collagen by cultured podocytes. Cell Physiol Biochem 2006; 17: 57-68.
30. Chen S, Lee JS, Iglesias-de la Cruz MC, Wang A, Izquierdo-Lahuerta A, Gandhi NK, Danesh FR, Wolf G, Ziyadeh FN. Angiotensin II stimulates α3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: implications for diabetic glomerulopathy. Nephrol Dial Transplant 2005; 20: 1320-8.